Participants who initiated long-acting cabotegravir-rilpivirine had a high rate of adherence and virologic suppression, with ...

Experts have proposed new treatment modes for older people with HIV. The new treatment does not cause the health-threatening ...

Thailand is examining the feasibility of adopting new global guidelines on long-acting HIV prevention, following the World Health Organisation's (WHO) launch of its latest recommendations for ...

The program known as PEPFAR is one of the most effective and popular U.S. foreign aid projects in history, and the government ...

Two monoclonal antibodies appeared safe and tolerable when administered alone or in combination to newborns exposed to HIV, according to a proof-of-concept study presented at the International AIDS ...

Researchers wanted to provide insight into the relative clinical value of Apretude and lenacapavir compared with no ...

A decade ago, the global community established the goal to end AIDS as a public health threat by 2030 through reducing new HIV infections and AIDS-related deaths by 90% from 2010 levels.1 Progress has ...

Long-acting injectable PrEP may improve access, protection and adherence, especially for young people and pregnant women, according to Hasina Subedar, a senior technical advisor at South Africa’s ...

Scientists, researchers, policy makers and HIV/AIDS advocates at a meeting in Kigali, Rwanda, from July 13-17 for the 13th ...

The International AIDS Society has announced the 2022 International AIDS Conference will take place in-person in Montreal. The conference, which will also feature virtual events, is scheduled to take ...

They are joint co-chairs of the International AIDS Society Initiative, Towards an HIV Cure. The views expressed in this commentary are their own. View more opinion on CNN. CNN — ...

As noted at AIDS 2022 by Dr. Chris Beyrer, the past president of the International AIDS Society and a professor public health at the Johns Hopkins University Bloomberg School of Public Health, ...